Cite
HARVARD Citation
Tanaka, Y. et al. (2021). Efficacy and Safety of E6011, an Anti‐Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double‐Blind, Placebo‐Controlled Phase II Study. Arthritis & rheumatology. 73 (4), pp. 587-595. [Online].